Physician profile
Javier Valle
NPI 1164685665
$154,949.39
in general payments reported to CMS, 2019-2025
27 companies · $2,869 in 2025
The $2,869 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $9,783 · 2021: $38K · 2022: $53K · 2023: $30K · 2024: $7,359 · 2025: $2,869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Travel and Lodging: $3,627 · Food and Beverage: $3,296 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,805.00 |
| Travel and Lodging | $3,627.23 |
| Food and Beverage | $3,296.20 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $117,273.87 | 2021-2024 | Xarelto |
| Cardiovascular Systems INC. | $11,455.47 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $10,850.00 | 2019 | |
| Siemens Medical Solutions USA, INC. | $4,628.00 | 2022 | |
| Abbott Laboratories | $2,757.96 | 2019-2025 | Amplatzer Talisman, Perclose Prostyle, Coroflow |
| Medtronic Vascular, INC. | $2,741.66 | 2019 | |
| Penumbra, INC. | $2,286.51 | 2021-2024 | Indigo System |
| Philips North America LLC | $702.29 | 2019 | |
| Edwards Lifesciences Corporation | $632.58 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $326.26 | 2019-2025 | Avvigo Guidance System, Ekosonic, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $196.45 | 2022-2025 | Corevalve Evolut R |
| Opsens INC. | $157.29 | 2019 | |
| Heartflow, INC. | $154.61 | 2019 | |
| Endologix LLC | $118.65 | 2019 | |
| Abiomed | $104.82 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $101.09 | 2023 | Assure Wcd |
| Shockwave Medical, INC | $96.66 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $63.30 | 2023-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.96 | 2024-2025 | Lifevest |
| Inari Medical, INC. | $50.89 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cordis US Corp. | $39.24 | 2025 | Mynx Control Venous |
| Stryker Corporation | $36.43 | 2025 | Inthrill Thrombectomy Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Intact Vascular, INC. | $32.29 | 2019 | |
| Cathworks, INC. | $28.71 | 2025 | Ffrangio |
| Bard Peripheral Vascular, INC. | $23.78 | 2021 | |
| Pfizer INC. | $15.29 | 2021 | |
| Terumo Medical Corporation | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Valle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.